Prior Intimation


General Information

NSE Symbol* NEOGEN
Name of the Company* Neogen Chemicals Limited
ISIN* INE136S01016
Type of Meeting 1)   Board Meeting
Details of Committee Meeting or Other Type of Meeting
Type of Intimation* New
Reason for Re-schedule (postpone or prepone) / Cancellation
Proposed Meeting Date 2026-02-11
Original Meeting Date
Whether trading window is closed* Yes
Trading Window Closure- Start date 2026-01-01
Details of Trading Window Closure End date 2026-02-13
Short Notice
Date of Report* 2026-02-06



Agenda Details

Agenda* 1)   Financial results
2)   Fund raising
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Standalone And Consolidated
Period end Type Quarterly
Period up to (Month) December
Period up to (Year) 2025
Mode of raising Funds 1)   To be ascertained
Type of Dividend
Remarks (website dissemination) to consider, evaluate and approve the proposal for raising of funds by way of issue of any instrument or security(ies) including equity shares, fully/ partly convertible/ non-convertible instruments including debenture warrants, and warrants entitling the warrant holder(s) to apply for equity shares or any other equity based instruments or eligible securities or any combination thereof in one or more tranche including by way of a public issue, qualified institution placements, preferential issue or a private placement in accordance with the applicable provision of the Companies Act 2013 and the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirement) Regulations, 2018, (each as amended) (“ICDR Regulations”), or through any other permissible mode or any combination thereof of any of the above to the eligible investors, in such manner, and on such terms and conditions as may be deemed appropriate by the Board in its absolute discretion, subject to the receipt of necessary approvals, including the approval of the members of the Company at a general meeting or through postal ballot and such other regulatory I statutory approvals as may be required.